QQ客服 官方微博 反馈留言

	YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR(L858R, T790M)-mutant resistance in vitro and in vivo
	Zhang, Zhang[1]; Zou, Jian[1]; Yu, Lei[2,3]; Luo, Jinfeng[3]; Li, Yan[4]; Tu, Zhengchao[3]; Ren, Xiaomei[1]; Wei, Hongcheng[5]; Song, Liyan[1]; Lu, Xiaoyun[1]
	2018
卷号	7期号:4页码:1430
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4478072
专题	暨南大学
作者单位	1.[1]Jinan Univ, Sch Pharm, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China 2.[2]Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 100049, Peoples R China 3.[3]Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave,Guangzhou Sci Pk, Guangzhou 510530, Guangdong, Peoples R China 4.[4]Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China 5.[5]Jinan Univ, Affiliated Hosp 5, 613 Huangpu Ave West, Guangzhou 510630, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Zhang, Zhang[1],Zou, Jian[1],Yu, Lei[2,3],et al. YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR(L858R, T790M)-mutant resistance in vitro and in vivo[J],2018,7(4):1430.
APA	Zhang, Zhang[1].,Zou, Jian[1].,Yu, Lei[2,3].,Luo, Jinfeng[3].,Li, Yan[4].,...&Ding, Ke[1].(2018).YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR(L858R, T790M)-mutant resistance in vitro and in vivo.,7(4),1430.
MLA	Zhang, Zhang[1],et al."YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR(L858R, T790M)-mutant resistance in vitro and in vivo".7.4(2018):1430.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。